Q&A: IBD wearable alerts patients ‘in real time’ about impending disease flares

What To Know

Healio reports on a wearable called IBD Aware (EnLiSense) that measures inflammation-related biomarkers in sweat — including CRP, fecal-calprotectin analogs in sweat, TNF‑α and IL‑6 — to track disease activity and alert patients and clinicians in near real time about rising inflammation that may precede a flare.

The device developers say it could be prescribed by clinicians (anticipated FDA 510(k) Class II pathway) and used either periodically or continuously depending on disease state and clinical judgment. The platform’s goal is to provide a temporal profile of biochemical signals to guide remote monitoring and decisions about follow-up labs or imaging.

The interview highlights potential patient benefits: earlier biochemical detection of rising inflammation before symptoms, longitudinal logging of actionable data, and the possibility of reducing unnecessary or inconvenient testing by targeting follow-up when biomarkers change.

Next steps and limitations discussed in the article include the need for regulatory review, tailoring wear schedules to individuals, and that timing of when a flare will occur relative to biomarker changes will vary between patients.